Eindhoven, Netherlands

Hans Willem Van Kesteren

This inventor holds 27 USPTO granted patents and 8 published patent applications and 12 EPO patents, primarily in Chemo-Optical Sensors. Top assignees: Koninklijke Philips Corporation N.v., U.S. Philips Corporation, Koninklike Philips N.v.. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Willem Van Kesteren. Retrieved from https://idiyas.com/inventor/hans-willem-van-kesteren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 27 

% Patents Active = 59.3

 

Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 107(Granted Patents)


Company Filing History:


Years Active: 1998-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Chemo-Optical Sensors
Gas Concentration Detection
Photoacoustic Technology
Respiratory Gas Detection
Signal Processing
Thermal Compensation
Magneto-Optical Recording
Magnetic Head
Data Recording
Osmotic Pressure Correction
Non-Reversible Cross Sensitivity
Cavity-Enhanced Detection
27 patents (USPTO):Explore Patents

Title: **Hans Willem Van Kesteren: Innovator in Optical Sensor Technology**

Introduction

Hans Willem Van Kesteren, a distinguished inventor based in Eindhoven, Netherlands, holds an impressive portfolio of 24 patents. His work primarily focuses on the development of advanced sensor technologies catering to gas concentration measurement. Van Kesteren's innovative spirit and technical expertise have made significant contributions to the field of optical sensors.

Latest Patents

Among his latest inventions, Van Kesteren has developed two noteworthy patents. The first, titled "Sensor for determining gas concentration," presents an optical sensor unit designed to measure gas concentration. This invention encompasses sensor means and thermal insulation, providing functionality for accurate gas detection through a sensing layer that responds to predetermined radiation.

The second patented innovation is the "Conditioning of chemo-optical sensors for transcutaneous application." This invention deals with a chemo-optical sensor unit for measuring gas concentrations through the skin. It incorporates a gas-permeable layer and utilizes a contact medium, allowing for the exchange of gas while maintaining sensitivity to concentration levels. This technology showcases the integration of biological elements with optical measurements, enhancing the potential for medical applications.

Career Highlights

Hans Willem Van Kesteren has worked for reputable companies such as Koninklijke Philips Corporation N.V. and U.S. Philips Corporation. His extensive experience within these organizations has provided him with a robust platform to innovate and advance optical sensor technologies. His career reflects a deep commitment to research and development, ultimately resulting in multiple patents that showcase his inventive capabilities.

Collaborations

Throughout his career, Van Kesteren has collaborated with notable colleagues, including Josephus Arnoldus Henricus Maria Kahlman and Nicolaas Lambert. These partnerships highlight the collaborative nature of scientific advancements and underscore the importance of teamwork in driving innovation.

Conclusion

Hans Willem Van Kesteren exemplifies the role of an inventor and innovator in the field of optical sensor technology. With a strong foundation in research and multiple patents to his name, he continues to contribute significantly to advancements that will likely play a crucial role in various applications, particularly in the medical sector. His work not only exemplifies technical skill but also illustrates the impact of innovative thinking in improving the way we understand and measure our environment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…